Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia.

导出 LinkOut

翻译打印收藏纠错

第一作者： Audrey,Delmas

第一单位： Otsuka Pharmaceutical Europe Ltd., Wexham, United Kingdom.

作者： Audrey,Delmas ^[1] ; Laurie,Batchelder ^[2] ; Ira,Arora ^[3] ; Solene,Bayet ^[4] ; David,Bruhn ^[5] ; Alice,Eberhardt ^[6] ; Stephanie,Philpott ^[2] ; Ana Maria,Rodriguez-Leboeuf ^[7]

作者单位： Otsuka Pharmaceutical Europe Ltd., Wexham, United Kingdom. ^[1] IQVIA, Reading, United Kingdom. ^[2] IQVIA, London, United Kingdom. ^[3] IQVIA, Courbevoie, France. ^[4] Otsuka Pharmaceutical Development & Commercialization Inc., Rockville, MD, United States. ^[5] Otsuka Pharma GmbH, Frankfurt am Main, Germany. ^[6] IQVIA, Madrid, Spain. ^[7]

关键词 acute myeloid leukemia hypomethylating agents oral treatment patient preference qualitative interview treatment preference

DOI 10.3389/fonc.2023.1160966

PMID 37223688

发布时间 2023-05-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2023年13卷

1160966页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除